Bartoloni Alessandro, Riccobono Eleonora, Magnelli Donata, Villagran Ana Liz, Di Maggio Tiziana, Mantella Antonia, Sennati Samanta, Revollo Carmen, Strohmeyer Marianne, Giani Tommaso, Pallecchi Lucia, Rossolini Gian Maria
Dipartimento di Medicina Sperimentale e Clinica, Università di Firenze, Ospedale di Careggi, Largo Brambilla 3, 50134 Firenze, Italy; SOD Malattie Infettive e Tropicali, Azienda Ospedaliero-Universitaria Careggi, Firenze, Italy.
Dipartimento di Biotecnologie Mediche, Università di Siena, Siena, Italy.
Int J Infect Dis. 2015 Jan;30:156-60. doi: 10.1016/j.ijid.2014.12.006. Epub 2014 Dec 5.
Information is lacking on the methicillin-resistant Staphylococcus aureus (MRSA) clonal lineages circulating in Bolivia. We investigated the prevalence and molecular epidemiology of S. aureus colonization in hospitalized patients from the Bolivian Chaco, and compared their features with those of the few clinical isolates available from that setting.
S. aureus nasal/inguinal colonization was investigated in 280 inpatients from eight hospitals in two point prevalence surveys (2012, n=90; 2013, n=190). Molecular characterization included genotyping (spa typing, multilocus sequence typing, and pulsed-field gel electrophoresis), detection of virulence genes, and SCCmec typing.
Forty-one inpatients (14.6%) were S. aureus nasal/inguinal carriers, of whom five were colonized by MRSA (1.8%). MRSA isolates mostly belonged to spa-type t701, harboured SCCmec IVc, and were negative for Panton-Valentine leukocidin (PVL) genes. However, a USA300-related isolate was also detected, which showed the characteristics of the USA300 Latin American variant (USA300-LV; i.e., ST8, spa-type t008, SCCmec IVc, presence of PVL genes, absence of arcA). Notably, all the available MRSA clinical isolates (n=5, collected during 2011-2013) were also identified as USA300-LV.
Overall, MRSA colonization in inpatients from the Bolivian Chaco was low. However, USA300-LV-related isolates were detected in colonization and infections, emphasizing the importance of implementing control measures to limit their further dissemination in this resource-limited area.
关于玻利维亚流行的耐甲氧西林金黄色葡萄球菌(MRSA)克隆谱系的信息尚缺。我们调查了来自玻利维亚查科地区住院患者中金黄色葡萄球菌定植的患病率及分子流行病学情况,并将其特征与该地区现有的少量临床分离株的特征进行比较。
通过两次现患率调查(2012年,n = 90;2013年,n = 190),对来自八家医院的280名住院患者进行金黄色葡萄球菌鼻/腹股沟定植情况调查。分子特征分析包括基因分型(spa分型、多位点序列分型和脉冲场凝胶电泳)、毒力基因检测及SCCmec分型。
41名住院患者(14.6%)为金黄色葡萄球菌鼻/腹股沟携带者,其中5人被MRSA定植(1.8%)。MRSA分离株大多属于spa型t701,携带SCCmec IVc,杀白细胞素(PVL)基因检测为阴性。然而,也检测到一株与USA300相关的分离株,其表现出USA300拉丁美洲变体(USA300-LV)的特征(即ST8、spa型t008、SCCmec IVc、存在PVL基因、无arcA)。值得注意的是,所有现有的MRSA临床分离株(n = 5,收集于2011 - 2013年)也被鉴定为USA300-LV。
总体而言,玻利维亚查科地区住院患者的MRSA定植率较低。然而,在定植和感染病例中均检测到与USA300-LV相关的分离株,这凸显了在这个资源有限地区实施控制措施以限制其进一步传播的重要性。